Crohn's disease trials in Canada

In Canada 48 Also abroad 422

48 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Where
Calgary, Edmonton, Greater Sudbury, London, Montreal, Québec, Vaughan
Age
18 years to 75 years
People
590 worldwide
Run by
AbbVie
See details and how to joinNCT06548542 · EU 2024-513009-30-00
No phaseNot yet taking people in Canada
Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development
Where
Vancouver
Age
18 years and over
People
95
Run by
University of British Columbia
See details and how to joinNCT07814274
No phaseTaking people
IBD Strong Peer2Peer for Self-Management of Psychological Distress
Where
Halifax
Age
18 years to 99 years
People
120
Run by
Jennifer Jones
See details and how to joinNCT05722236
No phaseNot yet taking people in Canada
A Mindfulness-based Stress Reduction Program for IBD
Where
Halifax
Age
18 years and over
People
70
Run by
Nova Scotia Health Authority
See details and how to joinNCT07266883
No phaseTaking people
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Where
Barrie, Brampton, Calgary, Fredericton, Hamilton, London, Mississauga, Montreal, Oakville, Oshawa, Toronto
Age
18 years and over
People
200
Run by
TIDHI Innovation Inc.
See details and how to joinNCT07245394
No phaseTaking people
Lesion Size Measurement During Gastrointestinal Endoscopies
Where
Montreal
Age
18 years and over
People
3,000
Run by
Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT07770425
No phaseTaking people
Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD
Where
Hamilton
Age
18 years to 70 years
People
300
Run by
McMaster University
See details and how to joinNCT07169123
Phase 3Taking people
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Where
Barrie, Calgary, Halifax, Hamilton, Montreal, Oshawa, Toronto, Vaughan, Winnipeg
Age
18 years to 65 years
People
396 worldwide
Run by
Takeda
See details and how to joinNCT06227910 · EU 2023-509391-42-00
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Edmonton, London, Montreal, Vancouver
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
No phaseTaking people
Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet
Where
Edmonton
Age
18 years and over
People
40
Run by
University of Alberta
See details and how to joinNCT06683105
Phase 3Taking people
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Where
Edmonton, London, Montreal, Vancouver
Age
2 years to 17 years
People
120 worldwide
Run by
Takeda
See details and how to joinNCT04779320 · EU 2023-509045-13-00
No phaseTaking people
Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease
Where
Vancouver
Age
9 years to 17 years
People
140
Run by
University of British Columbia
See details and how to joinNCT07314606
No phaseTaking people
Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease
Where
Vancouver
Age
19 years and over
People
80
Run by
University of British Columbia
See details and how to joinNCT07385807
Phase 2Taking people
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Where
Toronto
Age
18 years to 80 years
People
140 worldwide
Run by
Mirador Therapeutics, Inc.
See details and how to joinNCT07113522
No phaseTaking people
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
Where
Vancouver
Age
19 years to 80 years
People
100
Run by
University of British Columbia
See details and how to joinNCT06453720
Phase 4Taking people
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Where
Bridgewater, Calgary, Edmonton, London, Toronto
Age
18 years to 80 years
People
304 worldwide
Run by
Alimentiv Inc.
See details and how to joinNCT06257706 · EU 2023-509096-16-00
Phase 4Taking people
De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
Where
Montreal
Age
18 years and over
People
115
Run by
McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT07303686
No phaseTaking people
Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
Where
Calgary
Age
Up to 80 years
People
90
Run by
University of Calgary
See details and how to joinNCT07246460
No phaseTaking people
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
Where
Hamilton, London
Age
18 years and over
People
50 worldwide
Run by
Alimentiv Inc.
See details and how to joinNCT06670638
No phaseTaking people
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Where
Halifax
Age
8 years to 21 years
People
60 worldwide
Run by
Seattle Children's Hospital
See details and how to joinNCT06216899
No phaseTaking people
Threonine Requirement in Adult Males With Crohn's Disease Using IAAO
Where
Toronto
Age
18 years to 49 years
People
10
Run by
The Hospital for Sick Children
See details and how to joinNCT04740541
Phase 4Taking people
Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.
Where
Winnipeg
Age
18 years and over
People
418
Run by
University of Manitoba
See details and how to joinNCT06298461
No phaseEnrolling by invitation
Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease
Where
Sherbrooke
Age
18 years and over
People
120
Run by
Jean-François Beaulieu
See details and how to joinNCT06722456